Ovarian Endometrioid Carcinoma and Endometriosis Developing in a Postmenopausal Breast Cancer Patient during Tamoxifen Therapy: A Case Report and Review of the Literature

article OA: closed CC0 ⤵ 40 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-07

This case report details a postmenopausal breast cancer patient who developed ovarian endometrioid carcinoma and endometriosis while undergoing tamoxifen therapy, prompting a review of existing literature.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

We present the first case of ovarian endometrioid carcinoma and endometriosis in a postmenopausal patient who was treated with tamoxifen for breast cancer. The association with prolonged unopposed estrogen-like stimulation with tamoxifen as a possible factor in the development of ovarian endometrioid carcinoma is discussed.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Breast Neoplasms Carcinoma, Endometrioid Endometriosis Neoplasms, Second Primary Ovarian Neoplasms Postmenopause Tamoxifen Aged Breast Neoplasms Carcinoma, Endometrioid Carcinoma, Endometrioid Endometriosis Endometriosis Female Humans Neoplasms, Second Primary Ovarian Neoplasms Ovarian Neoplasms Tamoxifen

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (40)

Source provenance

europepmc
last seen: 2026-09-15T06:16:59.523076+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:18.900538+00:00
unpaywall
last seen: 2026-09-15T06:33:26.365676+00:00
License: CC0 · commercial use OK